Core Viewpoint - The Ademi Firm is investigating Brighthouse Financial for potential breaches of fiduciary duty related to its transaction with Aquarian Capital, which involves a cash offer of $70.00 per share, totaling approximately $4.1 billion [1][2]. Group 1: Transaction Details - Brighthouse Financial shareholders will receive $70.00 per share in an all-cash transaction valued at approximately $4.1 billion [2]. - The transaction agreement imposes significant penalties on Brighthouse Financial if it accepts competing bids, which raises concerns about the board's fiduciary duties [3]. Group 2: Investigation Focus - The investigation by the Ademi Firm centers on whether the Brighthouse Financial board of directors is fulfilling their fiduciary duties to all shareholders amidst the transaction [3].

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Golden Entertainment, Inc.'s operating assets and casino real estate assets to ensure that shareholders receive adequate consideration for their shares [1][3]. Group 1: Transaction Details - Golden shareholders will receive a fixed exchange ratio of 0.902 shares of VICI common stock and $2.75 from Blake Sartini for each share of Golden [1]. - The investigation focuses on whether the buyers are underpaying for Golden's assets and if the board of directors has fulfilled their fiduciary duties [3]. Group 2: Legal Rights and Options - Halper Sadeh LLC encourages Golden shareholders to contact them to learn about their legal rights and options regarding the proposed transaction [2][4]. - The firm may seek increased consideration for shareholders and additional disclosures related to the transaction [4].

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Forge Global Holdings, Inc. to The Charles Schwab Corporation for $45.00 per share in cash, raising concerns about whether shareholders are receiving adequate value for their shares [1][3]. Group 1: Investigation Details - The investigation focuses on potential violations of federal securities laws and breaches of fiduciary duties by Forge and its board, including failure to secure the best possible consideration for shareholders and not disclosing all material information necessary for assessing the merger [3]. - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other benefits related to the proposed transaction [4]. Group 2: Legal Rights and Contact Information - Forge shareholders are encouraged to contact Halper Sadeh LLC to learn about their legal rights and options regarding the sale [2]. - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [4].

Market Overview - U.S. stocks experienced a decline, with the Nasdaq Composite falling over 350 points, Dow down 0.60% to 47,053.04, Nasdaq down 1.65% to 23,441.48, and S&P 500 down 1.05% to 6,780.03 [1] - European shares were mostly lower, with the eurozone's STOXX 600 declining 0.30% and Germany's DAX 40 dipping 0.76% [6] - Asian markets closed lower, with Japan's Nikkei 225 falling 1.74% and Hong Kong's Hang Seng declining 0.79% [7] Company Performance - Uber Technologies reported a 20% year-over-year revenue growth to $13.47 billion, exceeding analyst estimates of $13.28 billion, and adjusted EPS of 81 cents, beating the consensus estimate of 69 cents, yet its stock fell over 6% [2] - Evoke Pharma shares surged 133% to $10.71 following an acquisition agreement with QOL Medical [8] - Denny's Corporation shares rose 50% to $6.16 after announcing an all-cash acquisition deal valued at approximately $620 million [8] - Norwegian Cruise Line Holdings Ltd shares dropped 15% to $18.86 after a revenue miss in the third quarter [8] - JELD-WEN Holding, Inc. shares fell 28% to $3.01 after reporting disappointing third-quarter results and lowering FY25 guidance [8] - Sarepta Therapeutics Inc shares decreased 31% to $16.82 after reporting third-quarter results and announcing that its ESSENCE study did not meet its primary endpoint [8] Commodities - Oil prices fell 0.5% to $60.77, gold decreased by 1.1% to $3,970.20, silver dropped 1.5% to $47.345, and copper fell 2.5% to $4.9450 [5] Economic Indicators - The Logistics Manager's Index remained unchanged at 57.4 in October, matching the previous month's reading [9]

Market Overview - U.S. stocks traded lower, with the Dow Jones index falling more than 400 points, down 0.91% to 46,906.05, NASDAQ down 1.59% to 23,456.33, and S&P 500 down 1.17% to 6,772.04 [1] - Consumer staples shares increased by 0.5%, while information technology stocks decreased by 1.8% [1] Pfizer Inc. Performance - Pfizer reported better-than-expected third-quarter earnings of 87 cents, compared to $1.06 a year ago, surpassing the consensus estimate of 63 cents [2] - Third-quarter sales fell 6% year-over-year to $16.65 billion, slightly above the consensus of $16.59 billion, reflecting an operational decline of 7% [2] - Pfizer raised its fiscal 2025 adjusted earnings guidance from $2.90-$3.10 per share to $3.00-$3.15, compared to the consensus of $3.04 [3] Commodity Market - Oil prices decreased by 1.2% to $60.34, gold fell by 1.8% to $3,943.90, silver dropped 2.6% to $46.780, and copper also fell 2.6% to $4.9355 [6] European Market Performance - European shares were lower, with the eurozone's STOXX 600 declining 0.7%, Spain's IBEX 35 down 0.5%, London's FTSE 100 down 0.4%, Germany's DAX 40 down 1.2%, and France's CAC 40 down 0.9% [7] Asian Market Performance - Asian markets closed lower, with Japan's Nikkei 225 down 1.74%, Hong Kong's Hang Seng down 0.79%, China's Shanghai Composite down 0.41%, and India's BSE Sensex down 0.62% [8] Notable Stock Movements - Evoke Pharma shares surged 135% to $10.74 after announcing an acquisition agreement with QOL Medical [9] - Denny's Corporation shares rose 50% to $6.16 following an acquisition announcement valued at approximately $620 million [9] - Prelude Therapeutics shares dropped 56% to $1.7601 after signing an acquisition agreement with Incyte [9] - JELD-WEN Holding shares fell 38% to $2.61 after reporting worse-than-expected third-quarter results and cutting FY25 guidance [9]

Company Performance - Pfizer Inc. reported better-than-expected earnings for Q3 2025, with adjusted earnings of 87 cents, surpassing the consensus estimate of 63 cents, although down from $1.06 a year ago [2] - Pfizer's Q3 sales fell 6% year over year to $16.65 billion, slightly beating the consensus of $16.59 billion, reflecting an operational decline of 7% [2] - Pfizer raised its fiscal 2025 adjusted earnings guidance from a range of $2.90-$3.10 per share to $3.00-$3.15, compared to the consensus of $3.04 [3] Market Movements - Evoke Pharma, Inc. shares surged 135% to $10.74 after announcing a definitive agreement to be acquired by QOL Medical [9] - Denny's Corporation shares increased by 50% to $6.16 following the announcement of an all-cash acquisition deal valued at approximately $620 million, or $6.25 per share [9] - Prelude Therapeutics Incorporated shares dropped 56% to $1.7601 after signing an agreement for Incyte to acquire its JAK2V617F JH2 inhibitor program [9] - JELD-WEN Holding, Inc. shares fell 38% to $2.61 after reporting worse-than-expected Q3 financial results and cutting its FY25 guidance below estimates [9]

Market Performance - U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Wednesday, while the Dow rose 0.18% to 44,319.31, the NASDAQ increased 0.62% to 20,545.29, and the S&P 500 climbed 0.31% to 6,245.11 [1] - Communication services shares increased by 1.1%, while consumer staples stocks dipped by 1% [1] Commodity News - Oil prices rose by 0.6% to $68.74, while gold prices fell by 0.1% to $3,315.70. Silver decreased by 0.4% to $36.610, and copper dropped by 3.8% to $5.4715 [5] European Market - European shares showed positive performance, with the eurozone's STOXX 600 rising 0.71%, Spain's IBEX 35 Index increasing by 1.07%, London's FTSE 100 gaining 0.13%, Germany's DAX 40 up by 1.32%, and France's CAC 40 rising by 1.40% [6] Asian Market - Asian markets closed mostly lower, with Japan's Nikkei gaining 0.33%, while Hong Kong's Hang Seng fell by 1.06%, China's Shanghai Composite declined by 0.13%, and India's BSE Sensex decreased by 0.21% [7] Company Developments - Calidi Biotherapeutics, Inc. saw its shares surge by 353% to $1.48 due to advancements in cancer treatment [9] - SU Group Holdings Limited's shares increased by 155% to $1.1609 after securing an HK$88.5 million hospital contract [9] - Evoke Pharma, Inc. shares rose by 171% to $7.20 following a notice of allowance for a U.S. patent application [9] - Bitmine Immersion Technologies, Inc. shares dropped by 47% to $59.22 after filing for a mixed shelf [9] - RxSight, Inc. shares fell by 42% to $7.39 after revising its 2025 revenue guidance downwards [9] - Vertical Aerospace Ltd. shares decreased by 31% to $4.77 after announcing a $60 million public offering at $5/share [9] Inventory Data - U.S. wholesale inventories declined by 0.3% month-over-month to $905.5 billion in May, aligning with preliminary estimates [11] - U.S. crude oil inventories increased by 7.070 million barrels in the week ended July 4, marking the largest gain since January [11]